---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-011079"
form_type: "8-K"
ticker: null
cik: "0001173281"
company_name: "NeuBase Therapeutics, Inc."
filed_at: "2023-06-14T23:59:59+00:00"
generated_at: "2026-06-14T00:53:22.224069+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# NeuBase Therapeutics to effect 1-for-20 reverse stock split to regain Nasdaq compliance

## Summary
- Reverse stock split at 1-for-20 effective 5:00 p.m. ET June 14, 2023; trading begins June 15 under symbol NBSE.
- Split intended to regain $1.00 minimum bid price for continued Nasdaq listing.
- Outstanding shares reduced from ~33.8 million to ~1.7 million.
- No fractional shares; cash paid in lieu based on June 13 closing price.
- Board approved ratio June 9, 2023; stockholder authorization received Sept 8, 2022.

## SEC filing metadata
- accession: 0001558370-23-011079
- form_type: 8-K
- cik: 0001173281
- company_name: NeuBase Therapeutics, Inc.
- filed_at: 2023-06-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173281/000155837023011079/0001558370-23-011079-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173281/000155837023011079/nbse-20230614x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-011079
- JSON: https://secwatch.observer/filing/0001558370-23-011079.json
- Plain text: https://secwatch.observer/filing/0001558370-23-011079.txt

## Key facts
- Governance Changes
  NeuBase Therapeutics, Inc.: Filed Certificate of Amendment to effect 1-for-20 reverse stock split (effective 2023-06-14).
  - Change: charter amendment
  - Effective: 2023-06-14
  source text: On June 14, 2023, NeuBase Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-20 reverse stock split of the Company’s shares of common stock (the “Reverse Stock Split”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1173281/000155837023011079/0001558370-23-011079-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.